VanEck Associates’s Alkermes ALKS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-119,502
| Closed | -$3.58M | – | 1409 |
|
|
2025
Q3 | $3.58M | Buy |
119,502
+1,690
| +1% | +$47.7K | ﹤0.01% | 872 |
|
|
2025
Q2 | $3.37M | Sell |
117,812
-34,579
| -23% | -$1.03M | ﹤0.01% | 859 |
|
|
2025
Q1 | $5.03M | Buy |
152,391
+14,824
| +11% | +$483K | 0.01% | 710 |
|
|
2024
Q4 | $3.96M | Buy |
137,567
+32,581
| +31% | +$937K | 0.01% | 775 |
|
|
2024
Q3 | $2.92M | Buy |
104,986
+29,998
| +40% | +$800K | ﹤0.01% | 828 |
|
|
2024
Q2 | $1.81M | Buy |
+74,988
| New | +$1.84M | ﹤0.01% | 913 |
|
|
2019
Q2 | – | Sell |
-1,603
| Closed | -$58K | – | 832 |
|
|
2019
Q1 | $58K | Buy |
1,603
+2
| +0.1% | +$66 | ﹤0.01% | 783 |
|
|
2018
Q4 | $47K | Buy |
1,601
+30
| +2% | +$1.11K | ﹤0.01% | 759 |
|
|
2018
Q3 | $67K | Sell |
1,571
-124,701
| -99% | -$5.41M | ﹤0.01% | 747 |
|
|
2018
Q2 | $5.2M | Buy |
126,272
+5,629
| +5% | +$256K | 0.02% | 299 |
|
|
2018
Q1 | $6.99M | Sell |
120,643
-50,473
| -29% | -$2.95M | 0.03% | 268 |
|
|
2017
Q4 | $9.37M | Sell |
171,116
-90,435
| -35% | -$4.62M | 0.05% | 231 |
|
|
2017
Q3 | $13.3M | Sell |
261,551
-856
| -0.3% | -$45.8K | 0.07% | 221 |
|
|
2017
Q2 | $15.2M | Buy |
262,407
+67,815
| +35% | +$3.94M | 0.08% | 188 |
|
|
2017
Q1 | $11.4M | Buy |
194,592
+11,353
| +6% | +$644K | 0.05% | 221 |
|
|
2016
Q4 | $10.2M | Sell |
183,239
-2,807
| -2% | -$150K | 0.05% | 221 |
|
|
2016
Q3 | $8.75M | Sell |
186,046
-27,939
| -13% | -$1.33M | 0.04% | 223 |
|
|
2016
Q2 | $9.25M | Sell |
213,985
-25,469
| -11% | -$1.05M | 0.05% | 207 |
|
|
2016
Q1 | $8.19M | Buy |
239,454
+354
| +0.1% | +$14K | 0.06% | 191 |
|
|
2015
Q4 | $19M | Buy |
239,100
+31,352
| +15% | +$2.2M | 0.15% | 134 |
|
|
2015
Q3 | $12.2M | Sell |
207,748
-42,765
| -17% | -$2.82M | 0.09% | 165 |
|
|
2015
Q2 | $16.1M | Buy |
250,513
+22,002
| +10% | +$1.35M | 0.1% | 172 |
|
|
2015
Q1 | $13.9M | Sell |
228,511
-2,147
| -0.9% | -$147K | 0.08% | 185 |
|
|
2014
Q4 | $13.5M | Buy |
+230,658
| New | +$11.7M | 0.08% | 177 |
|
|
2014
Q3 | – | Sell |
-256,361
| Closed | -$12.9M | – | 700 |
|
|
2014
Q2 | $12.9M | Sell |
256,361
-359,936
| -58% | -$16.6M | 0.06% | 179 |
|
|
2014
Q1 | $27.2M | Buy |
616,297
+248,561
| +68% | +$11.8M | 0.13% | 125 |
|
|
2013
Q4 | $15M | Buy |
+367,736
| New | +$13.6M | 0.08% | 152 |
|
Other funds holding ALKS
BBA
VanEck Associates's ALKS Position: Q4 2025 in Review
VanEck Associates sold out of Alkermes (ALKS) in Q4 2025, closing a stake of 119,502 shares — an estimated $3.58M sold.
VanEck Associates first reported a position in ALKS in Q4 2013 and held it in 27 quarters. The position peaked at $27.2M in Q1 2014. 366 funds tracked by Wall St. Rank hold ALKS as of Q4 2025.
- VanEck Associates reported no remaining Alkermes position as of Q4 2025 after selling out during the quarter.
- VanEck Associates sold 119,502 Alkermes shares in Q4 2025, an estimated $3.58M.
- VanEck Associates first reported a position in Alkermes in Q4 2013 and held it in 27 quarters.
- VanEck Associates's Alkermes position peaked at $27.2M in Q1 2014.
- 366 funds tracked by Wall St. Rank held Alkermes as of Q4 2025.
Based on VanEck Associates's 13F filing for Q4 2025, filed 13 Feb 2026.